CDC Archives - Amazing Health Advances

Poll: Almost Half of U.S. Respondents Demand Reevaluation of CDC Vaccine Schedule

The AHA! Team — Wed, 13 Aug 2025 05:33:15 +0000

Ramon Tomey via Natural News – In a striking shift, nearly half of U.S. respondents in an opinion poll now support reexamining the childhood vaccination schedule recommended by the Centers for Disease Control and Prevention (CDC). A poll by Children’s Health Defense reveals 49.4 percent of respondents favor reviewing the CDC’s childhood vaccination schedule, while only 29.6 percent oppose changes. Support rises to nearly 60 percent among parents of young children. While 43 percent still back school vaccine requirements, 39 percent argue public education access should not depend on vaccination status. New CDC appointees, including Martin Kulldorff, are scrutinizing vaccine safety, including cumulative effects of ingredients. Critics accuse the panel of promoting “anti-vaccine” views. Nearly half (48 percent) support legal recourse for vaccine-related harm, challenging the 1986 law shielding manufacturers from liability. The CDC’s review of thimerosal in flu shots revisits past autism concerns. The poll reflects eroded trust in vaccine mandates, signaling a shift away from unquestioned acceptance. In a striking shift, nearly half of U.S. respondents in an opinion poll now support reexamining the childhood vaccination schedule recommended by the Centers for Disease Control and Prevention (CDC). The survey, conducted by John Zogby Strategies and commissioned by Children’s Health Defense (CHD), polled 1,006 respondents from June 24 to 25. It found that 49.4 percent – 23.7 percent strongly support, 25.7 percent somehow support – are in favor of a reevaluation of the CDC’s vaccine schedule. In contrast, only 29.6 percent of respondents – 15.1 percent strongly oppose, 14.5 percent somewhat oppose – prefer to keep the vaccination schedule as is. The poll’s results also revealed that support for reviewing the vaccine schedule spikes to almost 60 percent among parents of young children – a demographic directly impacted by the recommendations. Under the current schedule, children must be injected with 70 doses of 15 vaccines by age 18. Meanwhile, 43 percent of respondents still endorse school vaccine mandates. Nevertheless, 39 percent of respondents argue public education access should remain unconditional instead of being contingent on compliance with vaccine mandates. (Related: MASS EXODUS from public schools anticipated after CDC advisory panel unanimously votes to add deadly Covid-19 “vaccines” to childhood immunization schedule.) People want vaccine injury accountability The opinion poll’s results come amid escalating scrutiny of federal vaccine policies, particularly after Health Secretary Robert F. Kennedy Jr. overhauled the CDC’s Advisory Committee on Immunization Practices (ACIP) with appointees who criticize mainstream vaccine guidance. Central to the controversy is a newly formed CDC work group tasked with studying the cumulative effects of childhood vaccines. “It is important to evaluate interaction effects between different vaccines, cumulative amounts of vaccine ingredients, and relative timing,” said new ACIP Chairman Martin Kulldorff during the panel’s June 25 meeting. His remarks echoed a 2013 National Academy of Medicine report urging deeper research into vaccine safety, a call left unheeded for over a decade. Critics, including mainstream medical groups, accuse the panel of veering toward anti-vaccine ideology. The American Academy of Pediatrics blasted Kulldorff’s suggestion to delay hepatitis B vaccinations as “unscientific” and “dangerous.” Typically given at birth, the new ACIP chairman said the injection can be delayed “unless the mother is hepatitis B positive.” Yet CHD CEO Mary Holland argues the poll reflects a public revolt against institutional dogma. “The constant fearmongering and shaming tactics … are not only ineffective, but backfiring,” she said. “This data clearly shows that the mainstream media, medical establishment and many politicians fail to hear the serious concerns of half of Americans on these vital issues.” Equally contentious is the 1986 National Childhood Vaccine Injury Act, which shields manufacturers from liability. Nearly half of respondents – 48 percent – now support legal recourse for vaccine injuries. In contrast, just 34 percent defend the status quo. This debate started in the 1990s, when mercury-based thimerosal first ignited autism concerns. Kennedy has long cited studies linking vaccines to neurological harm, though federal agencies and major medical journals reject those claims. Thimerosal was later removed from most childhood vaccines in 2001. The new ACIP’s review of thimerosal-preserved flu shots reignites that clash. Whether the CDC’s review yields policy changes or further polarization, one truth is clear. The era of unquestioned vaccine mandates is over. Sources include: ChildrensHealthDefense.org 1 ChildrensHealthDefense.org 2 [PDF] NBCNews.com Brighteon.com To read the original article, click here

The post Poll: Almost Half of U.S. Respondents Demand Reevaluation of CDC Vaccine Schedule appeared first on Amazing Health Advances.

CDC Study: Significantly Higher Lyme Disease Rates Among Older Adults Than Previously Reported

The AHA! Team — Mon, 23 Sep 2024 08:24:32 +0000

Dr. Sanchari Sinha Dutta, Ph.D. via News-Medical – The U.S. Centers for Disease Control and Prevention (CDC), in association with the University of Iowa, USA, has conducted an epidemiological study to determine the incidence rate of Lyme disease among older adults in the United States. The study is published in the CDC’s Emerging Infectious Diseases journal. Background Lyme disease, also known as Lyme borreliosis, is a vector-borne bacterial infection caused by a species of Borrelia bacteria that spreads to humans by the bite of infected black-legged ticks (Ixodes scapularis). The main symptoms are fever, headache, fatigue, and a specific type of skin rash called erythema migrans. While Lyme disease can present with a characteristic erythema migrans rash, it can also lead to severe complications if left untreated, including facial nerve paralysis, arthritis, and even heart rhythm irregularities. In the United States, Lyme disease most commonly occurs in the Northeast, mid-Atlantic, and upper-Midwest regions. Previous studies estimating the prevalence of the disease have used employer-sponsored insurance claims data to quantify the disease diagnoses. However, this type of data does not include information on individuals aged 65 years and above who exhibit higher susceptibility to Lyme disease than their younger peers. In this study, scientists have determined the incidence of Lyme disease among older adults in the United States using Medicare fee-for-service data that includes information on individuals aged 65 years and above. Study design The study analyzed Medicare fee-for-service data together with drug treatment data to identify Lyme disease diagnoses among individuals aged 65 years and above. The data collected during 2016 – 2019 was included in the analysis. The Medicare fee-for-service study population was compared with the 2019 US Census estimation data for individuals aged 65 years and above to ensure that the two groups were age-, sex-, race-, ethnicity- and region-matched. Lyme disease diagnoses identified in the Medicare fee-for-service data were compared with the confirmed and probable cases among individuals aged 65 years and above obtained through national surveillance. However, the study also notes certain limitations, such as slight differences between the Medicare fee-for-service population and the U.S. Census population regarding race, ethnicity, and sex. These differences, though small, were stable throughout the study period. Important observations The Medicare fee-for-service population included in the study was estimated to have a median of 17,872,466 person-years during the study period, as compared to the US Census population of 51,561,372 individuals aged 65 years and above. Person-years refer to the number of years for which persons contribute data. The proportion of individuals from neighboring high-incidence states was higher in the Medicare population than in the US Census population. Incidence of Lyme disease A total of 88,485 Lyme disease cases were identified in the Medicare population during the 2016-2019 study period. This corresponded to an average incidence of 123.5 diagnoses per 100,000 person-years. The total number of Lyme disease cases reported through public health surveillance during the same period was 34,183. This corresponded to an average incidence of 16.6 cases per 100,000 persons. Symptoms include fever, headache, fatigue, and a bullseye rash. Approximately 82% of Lyme disease cases were identified among individuals residing in high-incidence states. The median incidence of Lyme disease diagnoses was 346.9 per 100,000 person-years among residents of high-incidence states, 35.3 per 100,000 person-years among residents of states or jurisdictions neighboring high-incidence states, and 29.4 per 100,000 person-years among residents of low-incidence states. Public health surveillance data revealed that about 93% of Lyme disease cases were among residents of high-incidence states. The median incidence of these cases was 57.1 per 100,000 persons among residents of high-incidence states, 3.6 per 100,000 persons among residents of states or jurisdictions neighboring high-incidence states, and 0.6 per 100,000 persons among residents of low-incidence states. The majority of Lyme disease diagnoses occurred in the summer months. Among residents of low-incidence states, a large proportion of disease diagnoses occurred in winter months. According to Medicare and surveillance data, the majority of Lyme disease cases were identified among men. In high-incidence states, men had the highest incidence of Lyme disease for all age groups. In low-incidence states, women had a slightly higher incidence than men only in the 65–69-year age group and 75–79-year age group. Study significance The study identified more than 88,000 adults aged 65 years and above diagnosed and treated with Lyme disease during 2016 – 2019 in the United States. Most Lyme disease cases have been identified among residents of high-incidence states. The study reports a 7-fold higher incidence of Lyme disease diagnoses compared to that reported through public health surveillance. These findings are similar to the findings reported in previous claims analyses. The study also acknowledges the issue of overdiagnosis, which may partly explain the differences observed between the Medicare data and public health surveillance data. Overdiagnosis has been reported in other analyses and may contribute to the higher incidence rates observed in this older population. A variation in Lyme disease seasonality has been observed when Medicare fee-for-service data is compared with surveillance data. Some differences in gender-specific disease susceptibility have also been observed when this study is compared with previous claims analyses. Antibiotics like doxycycline are effective treatments. In previous claims analyses, male children have shown higher susceptibility to Lyme disease in both high- and low-incidence states. In contrast, male older adults have shown higher susceptibility in high-incidence states. Overall, the study findings add insight into Lyme disease patterns unique to this older population in the United States. Journal reference: Schwartz AM. 2024. Epidemiology of Lyme Disease Diagnoses among Older Adults, United States, 2016–2019. Emerging Infectious Diseases. https://wwwnc.cdc.gov/eid/article/30/9/24-0454_article To read the original article click here.

The post CDC Study: Significantly Higher Lyme Disease Rates Among Older Adults Than Previously Reported appeared first on Amazing Health Advances.

Evidence That Endocrine Disrupting Chemicals Are a Major Health Threat

AHA Publisher — Wed, 20 Apr 2022 07:00:53 +0000

Al Sears, MD, CNS – The autocrats at the CDC, EPA, and FDA continue to deny you’re in danger from the daily deluge of hormone-disrupting chemicals they’ve allowed into your environment. They have to know it’s a ridiculous lie. Each passing day brings more evidence these endocrine disrupting chemicals (EDCs) are a major threat. Synthetic chemicals like the bisphenol A (BPA) from plastics latch onto cellular receptors, increase estrogen production, reduce male fertility, and alter human metabolism. This sets the stage for massive chronic disease. You see, excess estrogen can destroy your health. It can even send you to an early grave. I’ve been blowing the whistle on endocrine disruptors for over two decades now, and at last the research community is beginning to wake up. Dr. Shanna H. Swan is a Mount Sinai medical center expert who initially accepted the EPA’s propaganda about EDCs… until her research validated a shocking global decline in human fertility. Now she’s crusading to alert the world to this massive threat. BPA Nosedive: Fertility and Health Fall Off a Cliff Together Among the stunning trends Dr. Swan documents: Plummeting masculinity: The sperm counts of men in the Western world dropped by over 59% from 1973 to 2011. She based her findings on 183 studies involving 42,935 men. Dr. Swan blames BPAs and other EDC toxins. Fading testosterone: The average male sex hormone level in men is dropping at about 1% a year. And there’s no sign the decline is leveling off. Crashing fertility: By 2045, Dr. Swan predicts that most couples who want to conceive will need artificial means such as IVF to have children… they simply won’t have enough reproductive capacity. Life-threatening consequences: One study showed women struggling with infertility had a 32% higher risk of dying.1 It’s even worse for men – those with abnormal sperm, or low sperm counts, had a 230% higher risk of dying.2 These are grim statistics… and I want to make sure that you don’t become one of them. Your Gameplan to Beat EDCs EDC Defense Protocol No. 1: Reduce Exposure – Start with the basics: Buy certified-organic fruits and veggies whenever possible. Use glass food containers not plastic, and never heat food in a plastic container unless you want a side helping of BPA with every meal. And do whatever you can to avoid fast food. It’s laced with EDCs… fast-food lovers have 40% higher BPA and phthalate blood levels.3 EDC Defense Protocol No. 2: Glutathione – Glutathione is a “seek and destroy” detoxifier that neutralizes environmental toxins and free radicals. Several studies indicate those who reach 100 are more likely to have higher levels of glutathione.4 More glutathione triggers better stem cell function.5 I recommend liposomal glutathione… it’s more absorbable. It can double immune-function biomarkers in a single week, including T cells and B cells.6 Start with a gram a day of liposomal glutathione… and gradually increase to 1 gram twice daily. EDC Defense Protocol No. 3: The Estrogen-Buster From Bali – Eugenol blocks estrogen imitators from locking onto cellular receptors, limiting the ability of EDCs to disrupt normal hormone levels. You’ll find clove oil and eugenol extract online and at your local supplement store. EDC Defense Protocol No. 4: Get Plenty of I3C and DIM – Indole-3 carbinol (I3C) is a special compound found in cruciferous vegetables such as brussels sprouts, broccoli, and cauliflower. Your body converts I3C into diindolylmethane (DIM). The I3C/DIM combo converts estrogen into harmless compounds your body easily excretes. I recommend 100 mg a day of I3C and DIM to protect you from EDCs. To Your Good Health, Al Sears, MD, CNS References: 1. Murugappan, Gayathree, et al. “Association between Infertility and All-Cause Mortality: Analysis of US Claims Data.” American Journal of Obstetrics and Gynecology, vol. 225, no. 1, 1 July 2021, pp. 57.e1–57.e11, NIH.gov website. 2. Eisenberg, M. L., et al. “Semen Quality, Infertility and Mortality in the USA.” Human Reproduction, vol. 29, no. 7, 15 May 2014, pp. 1567–1574, NIH.gov website. 3. Zota, Ami R, et al. “Recent Fast Food Consumption and Bisphenol a and Phthalates Exposures among the U.S. Population in NHANES, 2003-2010.” Environmental Health Perspectives, vol. 124, no. 10, 2016, pp. 1521–1528, NIH.gov website. 4. Andersen, H. R., Jeune, B., Nybo, H., Nielsen, J. B., Andersen-Ranberg, K., & Grandjean, P. (1998). Low activity of superoxide dismutase and high activity of glutathione reductase in erythrocytes from centenarians. Age and Ageing, 27(5), 643–648. 5. Jeong, E. M., Yoon, J.-H., Lim, J., Shin, J.-W., Cho, A. Y., Heo, J., … Kim, I.-G. (2018). Real-Time Monitoring of Glutathione in Living Cells Reveals that High Glutathione Levels Are Required to Maintain Stem Cell Function. Stem Cell Reports, 10(2), 600–614. 6. Sinha, R., Sinha, I., Calcagnotto, A., Trushin, N., Haley, J. S., Schell, T. D., & Richie, J. P. (2018). Oral supplementation with liposomal glutathione elevates body stores of glutathione and markers of immune function. European Journal of Clinical Nutrition, 72(1), 105–111.

The post Evidence That Endocrine Disrupting Chemicals Are a Major Health Threat appeared first on Amazing Health Advances.